Clinical Research Directory
Browse clinical research sites, groups, and studies.
Towards Optimal Treatment for High Risk Prostate Cancer
Sponsor: Haaglanden Medical Centre
Summary
The goal of this clinical trial is to combine several optimized treatments of high risk prostate cancer. The main question to answer is: is it safe to combine these optimized treatments. * patients will be irradiated on the prostate and (elective) lymph nodes more concentrated but with fewer hospital visits (hypofractionation) * the tumor will get a higher dose * androgen deprivation therapy will be reduced as much al possible preventing side effects Researchers will compare oncological outcome and toxicity.
Official title: Towards Optimal Treatment for High Risk Prostate Cancer; Stereotactic Pelvic Radiotherapy with Focal Boost to the Primary Tumour
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
207
Start Date
2024-01-02
Completion Date
2032-12-18
Last Updated
2024-09-19
Healthy Volunteers
No
Conditions
Interventions
HYPOPRIME treatment
Hypo fractionated pelvic radiotherapy with boost to primary tumour in the prostate with elective lymph node irradiation and minimized androgen deprivation therapy
Locations (1)
Haaglanden Medical Centre
Leidschendam, South Holland, Netherlands